Rear Adm. Krista Pedley’s promotion, and OPA’s new place within the HRSA administrator’s office, are symbolic of the 340B program’s growing importance in prescription drug pricing policy, and reflects how highly regarded Pedley is in HRSA and HHS.

Pedley’s Promotion May Presage Hiring of a New 340B Program Director

U.S. Public Health Service (PHS) Rear Adm. Krista Pedley, who has led the federal 340B drug pricing program for more than a decade, has been promoted within the U.S. Health Resources and Services Administration (HRSA) in conjunction with a major HRSA overhaul. HRSA is expected soon to invite individuals to apply to be her successor as director of HRSA’s Office of Pharmacy Affairs (OPA), the HRSA unit that runs the 340B program.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.